Prostate Cancer Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
Conditions: Prostate Cancer Interventions: Drug: DFMO; Drug: testosterone cypionate; Drug: Luteinizing hormone-releasing hormone (LHRH) analogue; Drug: Enzalutamide Sponsors: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Panbela Therapeutics; Prostate Cancer Foundation; United States Department of Defense Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 28, 2023 Category: Research Source Type: clinical trials

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy.
Conditions:   Prostate Cancer;   Prostatic Neoplasms Intervention:   Drug: 64Cu-SAR-bisPSMA Sponsor:   Clarity Pharmaceuticals Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy.
Conditions: Prostate Cancer; Prostatic Neoplasms Interventions: Drug: 64Cu-SAR-bisPSMA Sponsors: Clarity Pharmaceuticals Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials

Symmcora ® Long-term Bidirectional Barbed Suture for Anastomosis in Patients Undergoing Robot Assisted Radical Prostatectomy
Conditions: Prostate Cancer Interventions: Device: robotic assisted radical prostatectomy Sponsors: Aesculap AG; B.Braun Surgical SA Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials

Study of INKmune in Patients With mCRPC (CaRe Prostate)
Conditions: Cancer; Metastatic Castration-resistant Prostate Cancer; mCRPC Interventions: Biological: INKmune Sponsors: Inmune Bio, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials